merged_progeria-dna-base-editing.txt
<other>Reviewing the article carefully. It does not explicitly state who worked with Dr. Liu to develop the base editing system and is now leading the effort for progeria. Nor does it provide an expected timeline for FDA approval, only a goal to start a trial in two years or less.</other>
<question_number>1</question_number>
<answer>N/A</answer>
<question_number>2</question_number>
<answer>N/A</answer>